Distinct Molecular Abnormalities in Ovarian Carcinomas with BRCA1 Loss
Author Information
Author(s): Joshua Z Press, Alessandro De Luca, Niki Boyd, Sean Young, Armelle Troussard, Yolanda Ridge, Pardeep Kaurah, Steve E Kalloger, Katherine A Blood, Margaret Smith, Paul T Spellman, Yuker Wang, Dianne M Miller, Doug Horsman, Malek Faham, C Blake Gilks, Joe Gray, David G Huntsman
Primary Institution: University of British Columbia
Hypothesis
Can BRCA1 loss be used to subclassify high-grade serous ovarian carcinomas based on distinct molecular profiles?
Conclusion
High-grade serous carcinomas can be subclassified into three groups based on BRCA1 loss, each showing distinct molecular alterations.
Supporting Evidence
- Eighteen (37%) of the ovarian carcinomas had BRCA1 mutations or epigenetic loss.
- 47% of high-grade serous carcinomas showed loss of BRCA1.
- High-grade serous carcinomas with BRCA1 mutations had decreased PTEN mRNA levels.
Takeaway
This study looked at 49 ovarian cancer samples to see how BRCA1 loss affects the cancer's behavior, finding that different types of BRCA1 loss lead to different cancer characteristics.
Methodology
The study assessed mutations in BRCA1 and BRCA2, loss of heterozygosity, and BRCA1 promoter methylation in 49 ovarian cancer samples.
Limitations
The study excluded mucinous and borderline tumors and those who had received pre-operative chemotherapy.
Participant Demographics
Women diagnosed with invasive, non-mucinous epithelial ovarian carcinoma undergoing debulking surgery.
Statistical Information
P-Value
0.02
Statistical Significance
p=0.02
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website